In addition, higher Immune and Estimate Scores and lower Tumor Purity were associated with poorer OS in ccRCC patients (Fig. 2D), suggesting that the expression of TCIRG1 may be associated with changes in the TME during the diagnosis and prognosis of ccRCC. This evidence concerns the gene TCIRG1 and nonpapillary renal cell carcinoma.